Lasca

Ethinylestradiol / Levonorgestrel, the active ingredient in Lasca, is a combined oral contraceptive presented as a tablet for oral use. It prevents pregnancy in women of reproductive age by inhibiting ovulation and altering cervical mucus.

GNH USA supplies Lasca as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The product meets EU quality standards and is distributed under strict regulatory compliance. Our global network ensures reliable delivery and support for healthcare providers.

Lasca, a combined oral contraceptive, is indicated for several gynecological applications.

- Contraception: provides reliable prevention of pregnancy when taken as directed. - Management of dysmenorrhea: reduces menstrual pain and cramping. - Treatment of benign ovarian cysts: helps prevent the formation and growth of functional ovarian cysts.

Like all hormonal contraceptives, Lasca may cause a range of adverse reactions.

Common Side Effects: - Nausea - Breast tenderness - Headache

Serious or Rare Side Effects: - Venous thromboembolism (deep‑vein thrombosis, pulmonary embolism) - Arterial thrombosis (stroke, myocardial infarction) - Severe allergic reaction (anaphylaxis)

Before prescribing Lasca, clinicians should consider several safety factors. - Assess thrombotic risk: evaluate personal and family history of clotting disorders. - Screen for hypertension: measure blood pressure prior to initiation. - Avoid smoking in women over 35: counsel on cessation to reduce cardiovascular risk. - Monitor liver function: consider hepatic disease before use. - Counsel on missed pills: advise appropriate backup contraception. - Store at ambient temperature: keep in original packaging, protect from moisture and light.

Lasca can interact with other medicines, altering its effectiveness or safety.

Major Interactions (Avoid): - Enzyme‑inducing anticonvulsants (e.g., carbamazepine, phenytoin): may reduce contraceptive efficacy. - Rifampin and other rifamycins: decrease hormone levels, increasing risk of pregnancy. - St. John’s wort: herbal inducer that can compromise effectiveness.

Moderate Interactions (Monitor Closely): - Certain antibiotics (e.g., tetracycline, metronidazole): may slightly lower hormone levels. - Antifungal agents (e.g., fluconazole): can increase hormone concentrations. - Protease inhibitors used in HIV therapy: may alter contraceptive metabolism.